This fund aims to closely mirror the performance of the MSCI Emerging SRI S-Series PAB 5% Capped (NTR) index, identified by its Bloomberg ticker M7CXESC. It endeavors to maintain a maximum tracking error of just 1% relative to the index. This is accomplished through a synthetic replication strategy, where the fund invests in a diversified substitute portfolio, often comprising company stocks, various debt securities, and cash, rather than directly holding the index's constituents.